BioXcel Therapeutics, Inc.
BTAIQ
$0.05
$0.009.56%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -25.26% | -39.54% | -21.45% | 107.49% | -43.78% |
| Total Receivables | -62.04% | -7.30% | -- | -- | -- |
| Inventory | -3.40% | -30.75% | 57.30% | -9.29% | -21.18% |
| Prepaid Expenses | -22.08% | -2.06% | -29.21% | 10.49% | 8.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.27% | 6.91% | 443.17% | -2.67% | 54.15% |
| Total Current Assets | -15.36% | -24.12% | 0.64% | 75.90% | -33.18% |
|
|
|||||
| Total Current Assets | -15.36% | -24.12% | 0.64% | 75.90% | -33.18% |
| Net Property, Plant & Equipment | -15.38% | -49.35% | -40.62% | -28.75% | -22.22% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -15.36% | -24.25% | 0.28% | 73.69% | -33.13% |
|
|
|||||
| Total Accounts Payable | 15.61% | 10.52% | -9.68% | -2.49% | 8.04% |
| Total Accrued Expenses | -38.07% | 46.62% | 1.48% | -14.15% | 30.47% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 365.65% | -10.26% | 47.17% | 48.05% | 92.55% |
| Total Finance Division Other Current Liabilities | 0.83% | 0.14% | 5,938.27% | 50.00% | -52.21% |
| Total Other Current Liabilities | 0.83% | 0.14% | 5,938.27% | 50.00% | -52.21% |
| Total Current Liabilities | 149.39% | 1.98% | 42.65% | 13.27% | 30.65% |
|
|
|||||
| Total Current Liabilities | 149.39% | 1.98% | 42.65% | 13.27% | 30.65% |
| Long-Term Debt | -- | -8.04% | -8.28% | -5.30% | -2.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.87% | 275.20% | -50.35% | 38.07% | -20.25% |
| Total Liabilities | 3.36% | -0.58% | 4.99% | 0.19% | 3.66% |
|
|
|||||
| Common Stock & APIC | 0.76% | 0.42% | 0.97% | 8.73% | 0.30% |
| Retained Earnings | -2.01% | -1.76% | -1.77% | -4.57% | -2.92% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -9.40% | -10.56% | -7.36% | 17.41% | -19.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.40% | -10.56% | -7.36% | 17.41% | -19.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.40% | -10.56% | -7.36% | 17.41% | -19.40% |
|
|
|||||